ورود به حساب

نام کاربری گذرواژه

گذرواژه را فراموش کردید؟ کلیک کنید

حساب کاربری ندارید؟ ساخت حساب

ساخت حساب کاربری

نام نام کاربری ایمیل شماره موبایل گذرواژه

برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید


09117307688
09117179751

در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید

دسترسی نامحدود

برای کاربرانی که ثبت نام کرده اند

ضمانت بازگشت وجه

درصورت عدم همخوانی توضیحات با کتاب

پشتیبانی

از ساعت 7 صبح تا 10 شب

دانلود کتاب Flow Chemistry in Drug Discovery

دانلود کتاب شیمی جریان در کشف دارو

Flow Chemistry in Drug Discovery

مشخصات کتاب

Flow Chemistry in Drug Discovery

دسته بندی: علم شیمی
ویرایش:  
نویسندگان: , ,   
سری: Topics in Medicinal Chemistry, 38 
ISBN (شابک) : 3030855910, 9783030855918 
ناشر: Springer 
سال نشر: 2021 
تعداد صفحات: 501 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 31 مگابایت 

قیمت کتاب (تومان) : 54,000



ثبت امتیاز به این کتاب

میانگین امتیاز به این کتاب :
       تعداد امتیاز دهندگان : 5


در صورت تبدیل فایل کتاب Flow Chemistry in Drug Discovery به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.

توجه داشته باشید کتاب شیمی جریان در کشف دارو نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.


توضیحاتی در مورد کتاب شیمی جریان در کشف دارو



این کتاب چالش‌ها و فرصت‌های ناشی از شیمی جریان در کشف دارو را بررسی می‌کند و یک ابزار مرجع مفید برای شیمیدان‌های دارویی علاقه‌مند به سنتز ترکیبات فعال بیولوژیکی ارائه می‌کند.

که توسط همکاران متخصص تهیه شده است، فصل‌های مربوطه شامل نمی‌شود. فقط روش‌شناسی و واکنش‌های اساسی، مانند کاربرد کاتالیز، به‌ویژه بیوکاتالیز و کاتالیز ارگانیک. و تکنیک‌های فعال‌سازی غیر متعارف، از فتوشیمی تا الکتروشیمی. بلکه توسعه پنجره های فرآیند جدید، فرآیندها و واکنش ها در سنتز دارو. توجه ویژه ای به اتوماسیون و سنتز کتابخانه ای می شود که در صنعت داروسازی از اهمیت زیادی برخوردار است. خوانندگان همچنین موضوعات منتخب مورد علاقه عمومی را پوشش خواهند داد، مانند اینکه چگونه شیمی جریان به تحقیق و توسعه کشف دارو در کشورهای در حال توسعه کمک می کند، و ویژگی سبز این فناوری توانمند، به عنوان مثال در تولید مواد خام برای صنعت داروسازی از زباله .

با توجه به دامنه آن، این کتاب برای محققان شیمی دارویی که در دانشگاه و صنعت به طور یکسان کار می‌کنند و همچنین متخصصانی که در مقیاس‌سازی و توسعه دارو فعالیت می‌کنند، جذاب است.


توضیحاتی درمورد کتاب به خارجی

This book reviews the challenges and opportunities posed by flow chemistry in drug discovery, and offers a handy reference tool for medicinal chemists interested in the synthesis of biologically active compounds.

Prepared by expert contributors, the respective chapters cover not only fundamental methodologies and reactions, such as the application of catalysis, especially biocatalysis and organocatalysis; and non-conventional activation techniques, from photochemistry to electrochemistry; but also the development of new process windows, processes and reactions in drug synthesis. Particular attention is given to automatization and library synthesis, which are of great importance in the pharmaceutical industry. Readers will also find coverage on selected topics of general interest, such as how flow chemistry is contributing to drug discovery R&D in developing countries, and the green character of this enabling technology, for example in the production of raw materials for the pharmaceutical industry from waste.

Given its scope, the book appeals to medicinal chemistry researchers working in academia and industry alike, as well as professionals involved in scale-up and drug development.



فهرست مطالب

Preface
Contents
List of Abbreviations
Flow Chemistry in Drug Discovery: Challenges and Opportunities
	1 Introduction
		1.1 Introduction to Flow Chemistry
		1.2 Flow Chemistry Setup
		1.3 Types of Transformations
	2 The Drug Discovery Process in Pharma
	3 Flow Chemistry as a Tool to Improve Drug Discovery
		3.1 Green Components of Flow Chemistry
		3.2 Diversity Oriented Synthesis (DOS) in Flow
		3.3 Catalysis in Flow
			3.3.1 Hetero- and Homogeneous Catalysis
			3.3.2 Biocatalysis
			3.3.3 Photocatalysis
		3.4 Electrochemistry in Flow
		3.5 Library Synthesis and Automation Using Flow
		3.6 Artificial Intelligence (AI) and Flow Chemistry
	4 Conclusions and Outlook
	References
Green Aspects of Flow Chemistry for Drug Discovery
	1 Introduction
	2 Solvents
		2.1 Supercritical Fluids and Ionic Liquids
		2.2 Deep Eutectic Solvents
		2.3 Biomass-Derived Solvents
		2.4 Miscellaneous
	3 Enabling Technologies
		3.1 Photochemistry
		3.2 Electrochemistry
		3.3 Biocatalysis
		3.4 Microwaves
	4 Hazardous Reagents
		4.1 Azides
		4.2 Diazomethane
		4.3 Hydrogenation
		4.4 Carbonylation
		4.5 Miscellaneous
	5 Monitoring, Optimization, and Scale-Up in the Pharmaceutical Industry
		5.1 Monitoring
		5.2 Automatization
		5.3 3D Printing
		5.4 Optimization
		5.5 Process Intensification and Scale-Up
	6 Quantification of Sustainability (LCA)
	7 Conclusions
	References
Photochemistry in Flow for Drug Discovery
	1 Introduction
	2 Carbon-Carbon and Carbon-Heteroatom Bond Formation
		2.1 Diazonium Salts and Diazo Compounds for C-C and C-X Bond Formation
		2.2 Photoinduced Metal- and Dye-Catalysed C-C and C-X Bond Formation
		2.3 C-C Bond Formation via Photodecarboxylation
	3 Photochemical Cyclization Reactions
	4 Photochemical Rearrangement Reactions
	5 Incorporation of Fluorine and Fluorine-Containing Groups
	6 Trend to Photochemical-Assisted Biocatalysis
	7 Summary
	References
Electrochemistry in Flow for Drug Discovery
	1 Introduction
		1.1 General Introduction
		1.2 Introduction to Electrochemistry
		1.3 Fundamentals of Organic Electrochemistry
		1.4 Methods for Organic Electrosynthesis
			1.4.1 Controlled Potential Electrolysis (Potentiostatic)
			1.4.2 Constant Current Electrolysis (Galvanostatic)
		1.5 Cyclic Voltammetry
		1.6 Direct vs Indirect Electrolysis
		1.7 Types of Cells
			1.7.1 Batch Cells
			1.7.2 Flow Electrochemical Reactors
				Parallel Plate Flow Cells
				Thin-Layer Flow Cells
				Porous Flow Cells
				Automated Flow Electrolysis Platforms
	2 Flow Electrochemistry for Drug Discovery
		2.1 Flow Electrosynthesis of Pharmaceutically Relevant Scaffolds/Fragments
			2.1.1 Electrochemical Synthesis of Nitrile-Containing Scaffolds
			2.1.2 Electrochemical Synthesis of Benzoxazoles and Benzothiazoles
			2.1.3 Electrosynthesis of N-Containing Heterocycles by Nitrogen-Centred Radicals
			2.1.4 Electrochemical Anodic Aryl-Aryl Cross-Coupling in Flow Cells
			2.1.5 Electrosynthesis of N-Containing Heterocycles by Shono Oxidations
			2.1.6 Flow Electrochemical Synthesis for Chiral Selectivity
		2.2 Electrochemistry `On-Route´ to Small Molecule Drugs
		2.3 Flow Electrochemistry for Late-Stage Functionalisation
		2.4 Flow Electrochemistry for Metabolic Studies
		2.5 Automated Flow Electrosynthesis
		2.6 Conclusions
	References
Recent Advances of Asymmetric Catalysis in Flow for Drug Discovery
	1 Introduction
	2 Homogeneous Catalysis
		2.1 Hydrogenation and Hydroacylation
		2.2 Oxidation Reactions
		2.3 Other Types of Reactions with Transition-Metal Catalysts
		2.4 Other Types of Reactions with Organocatalysts
	3 Heterogeneous Catalysis
		3.1 Hydrogenation and Hydroformylation
		3.2 Organocatalysis
			3.2.1 Enamine-Iminium Catalysis
			3.2.2 Chiral Phosphoric Acid
			3.2.3 Other Types of Organocatalysis
		3.3 Transition-Metal Catalysis
		3.4 Lewis Acid Catalysis
		3.5 Biocatalysis
	4 Application for Multistep Synthesis of a Complex Molecule
	5 Perspective
	References
Multiple Organolithium Reactions for Drug Discovery Using Flash Chemistry
	1 Introduction
	2 Flash Chemistry
		2.1 Reactions Mediated by Decomposable Intermediates
		2.2 Reactions Mediated by Isomerizable Intermediates
		2.3 Reactions Mediated by Racemizable Intermediates
	3 Reaction Integration
		3.1 Linear Integration
		3.2 Convergent Integration
		3.3 Three-Component Coupling Based on Convergent and Linear Integration
	4 Conclusion
	References
Organocatalysis in Continuous Flow for Drug Discovery
	1 Introduction
	2 Achiral Organocatalysts in Continuous Flow
		2.1 Carbene Catalyzed Reactions
		2.2 Lewis Base Catalyzed Reactions
		2.3 Lewis Acid Catalyzed Reactions
		2.4 Photocatalytic Reactions
		2.5 Phosphine Catalyzed Reactions
	3 Chiral Organocatalysis in Continuous Flow
		3.1 Pyrrolidine-Derived Catalysts
		3.2 TRIP-Derived Catalysts
		3.3 Thiourea-Derived Catalysts
		3.4 Cinchona-Derived Catalysts
		3.5 Squaramide-Derived Catalysts
		3.6 Diamine-Derived Catalysts
		3.7 Imidazolidinone-Derived Catalysts
		3.8 Chiral Carbene-Derived Catalyst
	4 Direct Application of Organocatalysis in Continuous Flow for Drug Synthesis
	5 Conclusions
	References
Biocatalysis in Flow for Drug Discovery
	1 Introduction
		1.1 Biocatalysis in Drug Development
		1.2 Enzymes in Early-Stage Drug Discovery Approaches
		1.3 Flow Chemistry as an Enabling Tool for Enzymes
		1.4 To Immobilise or Not to Immobilise?
	2 Transaminase
		2.1 Transaminase in Continuous Flow
		2.2 Outlook for Transaminase in Continuous Flow
	3 Oxidoreductases
		3.1 Ketoreductase and Alcohol Dehydrogenase
		3.2 Application of KRED/ADH in Continuous Flow
		3.3 Outlook for KRED/ADH in Drug Discovery
		3.4 Other Oxidoreductases in Continuous Flow
			3.4.1 Imine Reductase in Continuous Flow
			3.4.2 Amine/Amino Acid Dehydrogenase
			3.4.3 Hydrogenase
			3.4.4 Oxidases in Continuous Flow
				Carbohydrate Oxidases
				Alcohol Oxidases
		3.5 Outlook for Oxidoreductases in Continuous Flow
	4 Chemoenzymatic Catalysis in Flow for Drug Discovery
		4.1 Chemoenzymatic Systems in Continuous Flow
		4.2 Outlook for Continuous Chemoenzymatic Processes for Drug Discovery
	5 Microreactors and Biocatalysis for Library Compounds Generation
		5.1 The Future of Microreactor Technology in Biocatalysis
	6 Miscellaneous Reactions
		6.1 Pickering Emulsion
		6.2 Esterifications
		6.3 Carboligation
		6.4 Lyases for Drug Synthesis
		6.5 Cyanation
		6.6 Protein Modification
		6.7 Cofactor Regeneration
	7 The Future of Flow Biocatalysis for Early-Stage Drug Discovery
	References
Improved Synthesis of Bioactive Molecules Through Flow Chemistry
	1 Introduction
	2 Synthesis of Bioactive Natural Products Under Continuous Flow Conditions
	3 Good Manufacturing Practice (GMP) and Continuous Good Manufacturing Practice (cGMP)
		3.1 API Manufacturing Under Continuous Flow Conditions
	4 Conclusion and Perspectives
	References
New Biomass Reagents for the Synthesis of Bioactive Compounds
	1 Introduction
	2 D-mannose as a Biomass Reagent for the Synthesis of Bioactive Compounds
	3 Furfural as a Biomass Reagent for the Synthesis of Bioactive Compounds
	4 Cashew Nutshell Liquid (CNSL) as a Biomass Reagent for the Synthesis of Bioactive Compounds
	5 Penicillium antarcticum as a Biomass Reagent for the Synthesis of Bioactive Compounds
	6 Conclusions
	References
Flow Chemistry Supporting Access to Drugs in Developing Countries
	1 Introduction
		1.1 Disease Burden and Pharmaceutical Landscape in Developing Countries
		1.2 Flow Chemistry in the Pharmaceutical Industry
	2 Continuous Flow Synthesis of APIs in Developing Countries
		2.1 Lamivudine
		2.2 Tenofovir
		2.3 Efavirenz
		2.4 Darunavir
		2.5 Isoniazid
		2.6 Ethambutol
		2.7 Levetiracetam and Brivaracetam
		2.8 Capecitabine
		2.9 Daclatasvir
		2.10 Clozapine
		2.11 Dimethyl Fumarate
		2.12 Mepivacaine and Its Analogues
		2.13 Oseltamivir Phosphate
		2.14 Nevirapine
		2.15 Dolutegravir
	3 Conclusion and Outlook
	References
Drug Discovery Automation and Library Synthesis in Flow
	1 Introduction
	2 Nanomole Reaction-Screening and Micromole-Scale Synthesis in Flow
		2.1 Introduction
		2.2 Nanomole-HTE in Batch
		2.3 Nanomole HTE in Flow: Instrument Development
		2.4 HTE in Flow: Instrument Validation
		2.5 HTE in Flow: Suzuki-Miyaura Coupling
	3 HTE in Flow for Photochemical Reaction Discovery
		3.1 Introduction
		3.2 System Setup and Validation
		3.3 In Droplet HTE Reaction Discovery
	4 Automated Radial Synthesis and Parallel Functionalization of Rufinamide in Flow
		4.1 Introduction
		4.2 Instrument Design
		4.3 Synthesis of Rufinamide and Derivatives in Flow
	5 Integrated Design-Make-Test Cycle Platform
		5.1 Introduction
		5.2 Abl Kinase Inhibitors
		5.3 DPP4 Inhibitors
	6 Conclusions and Outlook
	References




نظرات کاربران